CLINICAL_TRIALS
trial_result
· 2020-07-21
Clinical Trial Update: Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients [Phase 4]
Summary
Phase 4 clinical trial update exploring the relationship between improvements in insulin secretion and reductions in HbA1c in GLP-1 receptor agonist therapy for…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dasman Diabetes Institute | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN